Medicine
Showing 991-1,000 of 2,407 Results
-
Masataka Kawana
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Kawana is the Medical Director of the Ambulatory Heart Failure and Cardiomyopathy Service in the Advanced Heart Failure program. He completed his internal medicine, cardiovascular medicine, and heart failure training at Stanford. He also completed a postdoctoral research fellowship under Dr. James Spudich in the Department of Biochemistry. He manages advanced heart failure patients in the clinic, CCU/heart failure service, and post-heart transplant/MCS service. His research interests are in the fundamental mechanisms of inherited cardiomyopathies, and he studies the effect of gene mutations on cardiac sarcomere function using cutting-edge biochemical and biophysical approaches, which would lead to the development of novel pharmacotherapy that directly modulates cardiac muscle protein. He is involved in multiple clinical trials for pharmacotherapy and novel device studies in heart failure and inherited cardiomyopathy.
-
Joshua Keefe, MD, PhD
Affiliate, Department Funds
Resident in MedicineBioJoshua Keefe is a resident physician in the Stanford Internal Medicine Residency as part of the Translational Investigator Program. Josh received his BS in Bioengineering from UCLA and subsequently completed a postbaccalaureate research fellowship at the Framingham Heart Study before obtaining his MD and PhD from the Baylor College of Medicine. Josh completed his PhD under the mentorship of Dr. Xander Wehrens studying the role of macrophage-mediated inflammation in postoperative atrial fibrillation.
-
Kevin R Keet
Clinical Assistant Professor, Medicine
BioDr. Keet is an award-winning medical educator and hospitalist at the Palo Alto VA and Stanford University Hospitals, where he serves as Associate Program Director for the Internal Medicine residency. His clinical practice is grounded in a commitment to empathetic, patient-centered care, and he brings that same orientation to his work with trainees, helping residents develop the clinical reasoning and humanism that define excellent internists. His scholarly interests sit at the intersection of medical education and artificial intelligence, with a particular focus on how physicians can be prepared to use AI tools thoughtfully while preserving the cognitive skills and human judgment that patients depend on.
-
Vanessa Kennedy
Assistant Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
BioDr. Kennedy is a board-certified hematologist and medical oncologist who specializes in the treatment of myeloid malignancies, including acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and myelofibrosis (MF). She is an Assistant Professor in the Department of Medicine, Division of Blood and Marrow Transplantation & Cellular Therapy, at Stanford University School of Medicine.
Dr. Kennedy's research focuses on the use of clinical informatics and bioinformatics in understanding cancer biology and improving patient outcomes. She is also actively involved in interventional clinical trials. Her work has been supported by grant funding from the American Society of Clinical Oncology, the American Society of Hematology, and the Chan-Zuckerberg Foundation. -
Andreas Kerschbaumer
Postdoctoral Scholar, Immunology and Rheumatology
BioDr. Andreas Kerschbaumer is a postdoctoral scholar in the Division of Immunology and Rheumatology at Stanford University, conducting research in the Robinson and Khatri Labs. His work integrates clinical rheumatology with computational and systems immunology, applying meta-analytic techniques on transcriptomic datasets to uncover mechanisms of autoimmunity and improve therapeutic strategies in rheumatology.
He trained in internal medicine and rheumatology at the Medical University of Vienna, Department of Medicine III, Division of Rheumatology, where he also completed his PhD under Professors Smolen and Aletaha on treatment outcomes in inflammatory arthritis, followed by his habilitation on strategies to optimize the interpretation of clinical trial data in rheumatoid and psoriatic arthritis.
Dr. Kerschbaumer has been actively engaged with the European Alliance of Associations for Rheumatology (EULAR), contributing as Fellow, Methodologist, and Co-Methodologist to multiple international taskforces, including the 2019, 2022, and 2025 rheumatoid arthritis recommendations and the 2019 and 2023 psoriatic arthritis recommendations. He is currently a member of the EULAR Quality of Care Committee and serves as Co-Abstract Chair of the ACR Rheumatoid Arthritis abstract committee.
